Verona Pharma plc Annual Operating Income (Loss) in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Verona Pharma plc quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Verona Pharma plc Operating Income (Loss) for the quarter ending December 31, 2024 was -$18.3M, a 3.95% increase year-over-year.
  • Verona Pharma plc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$155M, a 129% decline year-over-year.
  • Verona Pharma plc annual Operating Income (Loss) for 2024 was -$155M, a 129% decline from 2023.
  • Verona Pharma plc annual Operating Income (Loss) for 2023 was -$67.6M, a 10.8% increase from 2022.
  • Verona Pharma plc annual Operating Income (Loss) for 2022 was -$75.8M, a 3.32% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$155M -$87.1M -129% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$67.6M +$8.18M +10.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$75.8M -$2.44M -3.32% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$73.3M +$964K +1.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$74.3M -$21.9M -41.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$52.4M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.